Search - tctmd.com

Displaying 1 - 7 of 7

Sort: Relevancy | Date

Presentation TCT 2022

TCT 344: UTILIZING CARDIAC CONTRACTILITY MODULATION THERAPY FIRST IN PATIENTS WITH LOW EF 25-35% IMPROVES LV FUNCTION AND HEART FAILURE STATUS WITHOUT THE NEED FOR CONCOMITATNT IMPLANTABLE DEFIBRILLATOR: EARLY US URBAN EXPERIENCE IN AN ACADEMIC TERTIARY…

Presenter: Majd Hemam

September 18, 2022

News Conference News TCT 2022

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Todd Neale

September 16, 2022

Presentation THT 2022

Question & Answers

Presenter: Vinay Thohan

February 02, 2022

Presentation THT 2022

The Clinical Story of CCM® – Looking ahead to HFpEF Population

Presenter: Javed Butler

February 02, 2022

Presentation THT 2022

Adopting CCM® Therapy into Practice – Sharing the European Experience

Presenter: Jurgen Kuschyk

February 02, 2022

Presentation THT 2022

Understanding the MoA of Cardiac Contractility Modulation

Presenter: Kanika Mody

February 02, 2022

Presentation THT 2022

Welcome and Introduction

Presenter: Vinay Thohan

February 02, 2022

Advertisement

TCT 344: UTILIZING CARDIAC CONTRACTILITY MODULATION THERAPY FIRST IN PATIENTS WITH LOW EF 25-35% IMPROVES LV FUNCTION AND HEART FAILURE STATUS WITHOUT THE NEED FOR CONCOMITATNT IMPLANTABLE DEFIBRILLATOR: EARLY US URBAN EXPERIENCE IN AN ACADEMIC TERTIARY…

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Question & Answers

The Clinical Story of CCM® – Looking ahead to HFpEF Population

Adopting CCM® Therapy into Practice – Sharing the European Experience

Understanding the MoA of Cardiac Contractility Modulation

Welcome and Introduction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content